NCT00005078View on ClinicalTrials.gov

Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

carboplatin

DRUG

paclitaxel

DRUG

tirapazamine

Trial Locations (4)

91105

City of Hope Medical Group, Pasadena

95817

University of California Davis Cancer Center, Sacramento

91010-3000

City of Hope Medical Center, Duarte

90033-0804

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00005078 - Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors | Biotech Hunter | Biotech Hunter